In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery

被引:114
作者
Chen, Fu [1 ]
Zhang, Zhi-Rong [1 ]
Yuan, Fang [1 ]
Qin, Xuan [1 ]
Wang, Minting [1 ]
Huang, Yuan [1 ]
机构
[1] Sichuan Univ, W China Sch Pharm, Minist Educ, Kay Lab Drug Targeting, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
N-trimethyl chitosan; nanoparticles; protein carriers; oral vaccination;
D O I
10.1016/j.ijpharm.2007.07.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, the effects of alginate modification on absorption properties of FITC-BSA loaded TMC nanoparticles were investigated on an in vitro model of GI epithelium (Caco-2 cells). The feasibility of applying TMC nanoparticles loaded with a model vaccine urease in oral vaccination was also studied. Alginate modified TMC nanoparticles showed higher FITC-BSA permeate efficiency than non-modified TMC nanoparticles. However, alginate modification barely had any effect on TMC nanoparticles' property of decreasing TEER or enhancing drug paracellular transport. Mice s.c. immunized with urease loaded TMC nanoparticles showed highest systematic immune response (IgG levels) but the lowest mucosal response (secretory IgA levels). In the contrast, mice i.g. immunized with urease loaded TMC nanoparticles showed much higher antibody titers of both IgG and secretory IgA than those with urease solution or urease co-administrated with TMC solution. These results indicated that TMC nanoparticles are potential carriers for oral protein and vaccine delivery. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:226 / 233
页数:8
相关论文
共 51 条
[1]   Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system [J].
Amidi, M ;
Romeijn, SG ;
Borchard, G ;
Junginger, HE ;
Hennink, WE ;
Jiskoot, W .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :107-116
[2]   N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model [J].
Amidi, Maryam ;
Romeijn, Stefan G. ;
Verhoef, J. Coos ;
Junginger, Hans E. ;
Bungener, Laura ;
Huckriede, Anke ;
Crommelin, Daan J. A. ;
Jiskoot, Wim .
VACCINE, 2007, 25 (01) :144-153
[3]   Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens [J].
Bacon, A ;
Makin, J ;
Sizer, PJ ;
Jabbal-Gill, I ;
Hinchcliffe, M ;
Illum, L ;
Chatfield, S ;
Roberts, M .
INFECTION AND IMMUNITY, 2000, 68 (10) :5764-5770
[4]   Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system [J].
Baudner, BC ;
Morandi, M ;
Giuliani, MM ;
Verhoef, JC ;
Junginger, HE ;
Costantino, P ;
Rappuoli, R ;
Del Giudice, G .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) :828-832
[5]   Preparation of coated nanoparticles for a new mucosal vaccine delivery system [J].
Borges, O ;
Borchard, G ;
Verhoef, JC ;
de Sousa, A ;
Junginger, HE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 299 (1-2) :155-166
[6]   Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers [J].
Chen, Fu ;
Zhang, Zhi-Rong ;
Huang, Yuan .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (01) :166-173
[7]   Lectin-mediated mucosal delivery of drugs and microparticles [J].
Clark, MA ;
Hirst, BH ;
Jepson, MA .
ADVANCED DRUG DELIVERY REVIEWS, 2000, 43 (2-3) :207-223
[8]  
Clark MA, 2001, VACCINE, V20, P208
[9]   NANOPARTICLES AND MICROPARTICLES FOR THE DELIVERY OF POLYPEPTIDES AND PROTEINS [J].
COUVREUR, P ;
PUISIEUX, F .
ADVANCED DRUG DELIVERY REVIEWS, 1993, 10 (2-3) :141-162
[10]   Mucosal delivery of vaccine antigens and its advantages in pediatrics [J].
De Magistnis, MT .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (01) :52-67